Dyslipidemia is a common finding in patients with thyroid disease, explained by the adverse
effects of thyroid hormones in almost all steps of lipid metabolism. Not only overt but also …

A kaleidoscope of coagulation disorders have been reported in patients with thyroid
dysfunctions. Globally, these disorders involve both primary and secondary hemostasis and …

Background and Purpose—The purpose of this study was to investigate whether thyroid
function and thyroid autoantibodies were associated with the risk of moyamoya disease in …

Brain white matter hyperintensities are more prevalent in migraine patients than in the
general population, but the pathogenesis and the risk factors of these hyperintensities are …

No consensus exists whether subclinical thyroid disease should be treated or just observed.
Untreated overt thyroid disease is associated with increased risk of cardiovascular disease …

OBJECTIVE: The aim of this study was to assess whether subclinical hypothyroidism (SCH)
is associated with carotid atherosclerosis, as well as dyslipidemia, and arterial hypertension …

Various abnormalities of coagulation and fibrinolysis, ranging from subclinical laboratory
abnormalities to clinically significant disorders of hemostasis, but rarely major hemorrhage …

We report a patient and critically review the literature in order to define the demographic,
clinical, neuroradiologic, and treatment features of moyamoya syndrome (MMS) in the …

Background: It is unclear whether in late life serum thyroid-stimulating hormone (TSH)
predicts risk of developing cognitive impairment. Objective: This study investigated the …

The pathogenesis of moyamoya disease remains unknown. Examination of diseases
concurrent with moyamoya disease may offer a clue to clarify the pathogenesis. Coexistence …